These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3262097)

  • 1. The effect of acetazolamide on regional cerebral blood flow in normal human subjects as measured by single-photon emission computed tomography.
    Bonte FJ; Devous MD; Reisch JS
    Invest Radiol; 1988 Aug; 23(8):564-8. PubMed ID: 3262097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of acetazolamide on regional cerebral blood flow in patients with Alzheimer's disease or stroke as measured by single-photon emission computed tomography.
    Bonte FJ; Devous MD; Reisch JS; Ajmani AK; Weiner MF; Hom J; Tintner R
    Invest Radiol; 1989 Feb; 24(2):99-103. PubMed ID: 2783927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral vasoreactivity assessed with transcranial Doppler and regional cerebral blood flow measurements. Dose, serum concentration, and time course of the response to acetazolamide.
    Dahl A; Russell D; Rootwelt K; Nyberg-Hansen R; Kerty E
    Stroke; 1995 Dec; 26(12):2302-6. PubMed ID: 7491655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: a PET study with the acetazolamide test in cerebrovascular disease.
    Okazawa H; Yamauchi H; Toyoda H; Sugimoto K; Fujibayashi Y; Yonekura Y
    J Nucl Med; 2003 Dec; 44(12):1875-83. PubMed ID: 14660711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease.
    Okazawa H; Yamauchi H; Sugimoto K; Takahashi M
    J Nucl Med; 2003 Sep; 44(9):1371-8. PubMed ID: 12960179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of time dependency of the acetazolamide effect on cerebral hemodynamics as measured by 99mTc-ECD single-photon emission computed tomography].
    Takaki A; Mizuta Y; Murakami M; Yonehara T; Urata J; Okada K; Takaki R; Hirano T; Fujioka S
    Kaku Igaku; 2001 Jan; 38(1):31-8. PubMed ID: 11257761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-day protocol for cerebral perfusion reserve with acetazolamide.
    Hattori N; Yonekura Y; Tanaka F; Fujita T; Wang J; Ishizu K; Okazawa H; Tamaki N; Konishi J
    J Nucl Med; 1996 Dec; 37(12):2057-61. PubMed ID: 8970534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of technetium-99m hexamethylpropylene amine oxime SPET for the study of cerebral blood flow reactivity after acetazolamide infusion in patients with Behçet's disease.
    Pupi A; Sestini S; De Cristofaro MT; Emmi L; Marchione T; Salvati G; Gobbi FL; Massacesi L; Meldolesi U
    Eur J Nucl Med; 2000 Jun; 27(6):700-6. PubMed ID: 10901457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional cerebral blood flow and cerebrovascular reactivity in IDDM.
    Rodriguez G; Nobili F; Celestino MA; Francione S; Gulli G; Hassan K; Marenco S; Rosadini G; Cordera R
    Diabetes Care; 1993 Feb; 16(2):462-8. PubMed ID: 8432218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of acetazolamide on cerebral artery blood velocity and regional cerebral blood flow in normal subjects.
    Sorteberg W; Lindegaard KF; Rootwelt K; Dahl A; Nyberg-Hansen R; Russell D; Nornes H
    Acta Neurochir (Wien); 1989; 97(3-4):139-45. PubMed ID: 2785746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of delayed appearance of acetazolamide effect in patients with chronic cerebrovascular ischemic disease: feasibility and usefulness of SPECT method using triple injection of ECD.
    Murakami M; Yonehara T; Takaki A; Fujioka S; Hirano T; Ushio Y
    J Nucl Med; 2002 May; 43(5):577-83. PubMed ID: 11994517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the dual-table autoradiographic method to quantify two sequential rCBFs in a single SPET session with N-isopropyl-[123I] p-iodoamphetamine.
    Nishizawa S; Iida H; Tsuchida T; Ito H; Konishi J; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):943-50. PubMed ID: 12734690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET.
    Takeuchi R; Yonekura Y; Matsuda H; Konishi J
    Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):331-41. PubMed ID: 12002707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive quantitative measurements of regional cerebral blood flow using technetium-99m-L,L-ECD SPECT activated with acetazolamide: quantification analysis by equal-volume-split 99mTc-ECD consecutive SPECT method.
    Takeuchi R; Matsuda H; Yonekura Y; Sakahara H; Konishi J
    J Cereb Blood Flow Metab; 1997 Oct; 17(10):1020-32. PubMed ID: 9346426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of quantification analysis software for measuring regional cerebral blood flow by the modified split-dose method with (123)I-IMP before and after acetazolamide loading].
    Nagaki A; Kobara K; Matsutomo N
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2003 Dec; 59(12):1573-9. PubMed ID: 15001874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral perfusion and haemodynamics measured by SPET in symptom-free patients with transient ischaemic attack: clinical implications.
    Martí-Fàbregas JA; Catafau AM; Marí C; Mendoza G; Sanahuja J; Lleó A; Martí-Vilalta JL
    Eur J Nucl Med; 2001 Dec; 28(12):1828-35. PubMed ID: 11734922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of cerebral perfusion and cerebrovascular reserve in insulin-dependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide.
    Jiménez-Bonilla JF; Quirce R; Hernández A; Vallina NK; Guede C; Banzo I; Amado JA; Carril JM
    Eur J Nucl Med; 2001 Nov; 28(11):1647-55. PubMed ID: 11702106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of acetazolamide on cerebrovascular function and breathing stability at 5050 m.
    Fan JL; Burgess KR; Thomas KN; Lucas SJ; Cotter JD; Kayser B; Peebles KC; Ainslie PN
    J Physiol; 2012 Mar; 590(5):1213-25. PubMed ID: 22219343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide.
    Soricelli A; Postiglione A; Cuocolo A; De Chiara S; Ruocco A; Brunetti A; Salvatore M; Ell PJ
    Stroke; 1995 Sep; 26(9):1572-6. PubMed ID: 7660400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.